文献速递免疫规划卫生政策与健康促进

造血干细胞移植后再次接种疫苗:印度当前实践调查

Post stem cell transplantation revaccination: A survey of the current practices in India.
PubMed 文献 · Vaccine · 2018-03-09

该横断面调查通过电子邮件向印度105名移植医生发放36题问卷,评估其对2015年印度干细胞移植登记处(ISCTR)移植后疫苗接种指南的依从性。62%的医生回复,代表印度78.8%的移植中心;超过90%的异基因移植医生和64%的自体移植医生提供疫苗接种,42%的受访者不知晓该指南,仅47%报告完全遵循其所采用方案。

要点

  • 超过90%异基因移植医生和64%自体移植医生提供疫苗接种。
  • 42%受访者不知晓ISCTR移植后疫苗接种方案,仅47%完全遵循所采用方案。
  • 不足三分之一医生提供甲型肝炎、伤寒或脑膜炎球菌感染疫苗接种。

核心结论

  • 需要改进造血干细胞移植受者疫苗接种的实施策略,以提高依从性并在移植物抗宿主病存在时继续接种,同时需要扩大对印度高发疫苗可预防疾病的疫苗接种。

研究设计与样本

  • 横断面调查,作为定量研究策略探索印度移植医生的疫苗接种实践,问卷包含36个预设问题,理论构念经表面效度验证,通过电子邮件附件或谷歌表单发放,按互联网电子调查结果报告清单声明报告。
  • 调查表发送给印度105名移植医生,62%的医生回复,代表印度78.8%的移植中心。

主要发现

  • 超过90%的异基因移植医生和64%的自体移植医生提供疫苗接种。
  • 超过三分之二的医生回复在慢性移植物抗宿主病(cGVHD)发生时会停止接种疫苗。
  • 不足三分之一的医生提供甲型肝炎、伤寒或脑膜炎球菌感染疫苗接种。
  • 42%的受访者不知晓ISCTR移植后疫苗接种方案,仅47%的受访者报告完全遵循其所采用方案。
  • 仅13.3%的受访者可获得指导疫苗接种的免疫重建信息。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Hematopoietic stem cell transplant (HSCT) recipients are more susceptible to infections from vaccine preventable diseases (VPDs) than the general population. Indian stem cell transplant registry (ISCTR) post-BMT vaccination guidelines were formulated in 2015. The objective of the survey was to assess the compliance to these guidelines among transplant physicians in India. MATERIALS AND METHODS: This is a cross-sectional survey executed as the quantitative research strategy to explore the various aspects of vaccination practices among transplant physicians in India. The 'data collection tool' included 36 predetermined questions related to vaccination of the patients and their close contacts. Theoretical construct of the questionnaire was face-validated and questionnaire survey forms were emailed individually as attachments or by google forms. This study is being reported based on the checklist for reporting results of internet e-surveys statement guidelines. RESULTS: Survey forms were sent to 105 transplant physicians in India, 62% of whom responded representing 78.8% of transplant centers in India. More than 90% of allogeneic transplant physicians and 64% of autologous transplant physicians offered vaccination. Over two third of the physicians responded that they would discontinue vaccination at the onset of cGVHD. Fewer than one third physicians offered vaccination against Hepatitis A, Typhoid or Meningococcal infections. Forty two percent of respondents were unaware of the ISCTR post-BMT vaccination protocol. Only 47% of respondents reported complete adherence to any of the protocols they were following. Immune reconstitution to guide vaccination was available only to 13.3 percent of respondents. CONCLUSION: There is a need to improve the implementation strategies of vaccination in HSCT recipients to increase the adherence and continuation of it even in the presence of GVHD. There is also a need to extend the vaccination among VPDs especially prevalent in India.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. John MJ, Mathew A, Bhat S, et al. Post stem cell transplantation revaccination: A survey of the current practices in India. Vaccine. 2018. PMID: 29530635. doi:10.1016/j.vaccine.2018.02.084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。